Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Nycomed Announces FDA Filing For Daxas(R) In COPD
Nycomed announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Daxas® as a once-daily oral treatment for patients with symptomatic COPD. The NDA submission is based on encouraging results from four Phase III trials of Daxas® (roflumilast) in the treatment of symptomatic COPD. Two pivotal 12-month studies showed positive effects on exacerbation rates and pulmonary function (FEV1). Two supporting six-month studies also confirmed the efficacy of Daxas when used with standard bronchodilator treatments. Full data from all four studies are to be published during 2009.

A Phase III Alzheimer's Drug Increases Levels Of Beta Amyloid In The Brain -- But Still Provides Benefits
Surprising new insights into how a Phase III Alzheimer"s drug might work
News of the day
ICES Study Finds More Ontario Children Being Diagnosed With Diabetes
Ontario children are more likely to get diagnosed with diabetes than their American counterparts. A study out of the Institute for Clinical Evaluative Sciences (ICES) has found a 3 per cent increase per year in the rate of diabetes in Ontario children from 1994 to 2004.
Sexual Health

My Prostate Cancer Operation - A Personal Diary

and incredibly powerful!! Other related articles *What is Prostate Cancer? I will soon write about the following four weeks, including the removal of the catheter, the histology report, etc. As soon as I have written it, a link to that article will appear here. If you had your prostate taken out, or have had prostate cancer treatment, why not share your experience? See our opinions link at the top of this page. News on Prostate and Prostate Cancer For the latest news and research on Prostate and Prostate Cancer, and to sign up to newsletters or news alerts, please visit our Prostate and Prostate Cancer section. Written by - Christian Nordqvist, CEO and Editor of Medical News Today Copyright: Medical News Today Not to be reproduced without permission of Medical News Today

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009